Jun 243 minCONNECT grows to 30 partners CONNECT welcomes the two new partners Gilead Sciences Nordic Region and the Norwegian Directorate for E-health.
Jun 22 minCONNECT seminar on Digital Pathology and AIExperts from regional, national and international groups shared their perspectives on digital pathology and artificial intelligence (AI)...
May 44 minNorwegian cancer initiatives receive international attention Norway is pioneering precision medicine in cancer with three nation-wide initiatives.
Mar 222 minCONNECT seminar om NukleærmedisinNukleærmedisin med presisjonsdiagnostikk og persontilpasset behandling. Nukleærmedisin omfatter både diagnostikk og behandling ved bruk...
Dec 10, 20211 minGSK is CONNECT's 6th new partner in 2021, and sponsor of the Cancer Crosslinks 2022CONNECT’s newest partner, GSK, sponsors the Cancer Crosslinks 2022, and is increasing its focus on oncology and hematology. These are...
Dec 8, 20212 minCONNECT Seminar on Clinical Decision Support SystemsClinical Decision Support Systems: useful for what and for whom? In his introduction, Eivind Hovig, Professor at the Centre for...
Oct 20, 20212 minCONNECT's partner, Eli Lilly & Company, is now part of the IMPRESS studyCONNECTs partner Eli Lilly & Company is now offering participants of the IMPRESS study a new and promising medicine.
Oct 13, 20212 minCONNECT seminar: The new EU regulations on IVDR – how to be prepared?CONNECT seminar: The new EU regulations on IVDR – how to be prepared?
Sep 16, 20211 minThe winner of King Olav V’s Prize for Cancer Research 2021 is Bjørn Tore GjertsenThis year’s King Olav V’s Prize for Cancer Research will go to Professor Bjørn Tore Gjertsen, one of CONNECT’s Steering Committee...